SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

XRP is trending as traders closely monitor a high-stakes Senate cloture vote on the Digital Asset Market Clarity Act, debating whether the legislation will pass or lead to a market sell-off. While some investors are bullish on the potential for regulatory progress, others are skeptical, characterizing the event as political theater or a "sell the news" scenario.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is trending as traders speculate on upcoming maintenance study results, with sentiment heavily divided between bullish conviction in the drug's efficacy and frustration over the CEO's communication style and lack of transparency regarding trial data. While the company's scientific potential remains the dominant conversation, there is significant debate surrounding the timing of the data release and the possibility of a partnership or acquisition.

Circle Internet Group, Inc. is a financial technology company that enables businesses of all sizes to harness the power of digital currencies and public blockchains for payments, commerce and financial applications worldwide. The company was founded by Jeremy J. Allaire and Patrick Sean Neville in August 2013 and is headquartered in New York, NY.

Circle Internet Group Inc. - Ordinary Shares - Class A

Circle

Circle is trending amid heightened focus on the upcoming Senate procedural vote for the CLARITY Act, with traders divided over the bill's prospects and its potential impact on stablecoin yield provisions. Sentiment remains bearish as some investors express concern over increasing competition from traditional banking institutions and recent insider share sales.

Cava Group, Inc. is a holding company, which engages in the category-defining Mediterranean fast-casual restaurant brand, bringing together healthful food and bold, satisfying flavors at scale. It operates through the following segments: CAVA and CAVA Foods. The CAVA segment includes the operations of all company-owned CAVA restaurants. The CAVA Foods segment includes the production of dips and spreads used in CAVA restaurants as well as sales from the consumer-packaged goods (CPG) business. The company was founded by Brett Schulman, Ike Grigoropoulus, Dimitri Moshovitis, and Theodore Xenohristos in 2010 and is headquartered in Washington, DC.

Cava Group Inc

CAVA Group Inc

CAVA is trending following a significant stock price decline driven by sector-wide weakness in fast-casual dining and investor caution regarding consumer spending in an inflationary environment. While some investors remain optimistic about the company's long-term growth and unit expansion, others are concerned about its high valuation and the sustainability of sales growth as the consumer base faces financial pressure.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbase shares are volatile as the community debates the outcome of the Senate's procedural vote on the CLARITY Act, with traders divided on whether the legislation has enough bipartisan support to pass or if the vote will result in a "sell-the-news" event. The stock is also reacting to broader crypto market movements and a mix of analyst upgrades and selling pressure from institutional funds.

Forgent Power Solutions, Inc. is a holding company, which engages in the design and manufacture of electrical distribution equipment used in data centers, power grid, and energy-intensive industrial facilities. It also offers powertrain solutions and standard and custom products. The company was founded on July 21, 2025 and is headquartered in Dayton, MN.

Forgent Power Solutions Inc. - Ordinary Shares - Class A

Forgent Power Solutions Inc.

Forgent Power Solutions is receiving attention following record fiscal fourth-quarter results and strong fiscal 2027 guidance, which highlighted a record backlog and significant revenue growth. Traders are discussing the company's expansion plans, including a new manufacturing facility to support growing data center and power infrastructure demand, while debating potential volatility and price targets.

Chipotle Mexican Grill, Inc. engages in the business of developing and operating restaurants that serve a relevant menu of burritos, burrito bowls, quesadillas, tacos, and salads made using fresh, high-quality ingredients. The company was founded by Steve Ells in 1993 and is headquartered in Newport Beach, CA.

Chipotle Mexican Grill

Chipotle is experiencing a sell-off as traders react to reports of a salmonella outbreak linked to jalapeños supplied to certain locations. While some investors view the price drop as a buying opportunity given the company's swift removal of the affected product and minimal ongoing operational risk, others are expressing concern over negative headlines and the potential for a deeper downtrend.

QXO, Inc. is a publicly traded distributor of roofing, waterproofing and complementary building products in the United States. It plans to become tech-enabled in the building products distribution industry and generate outsized value for shareholders. The company was founded on October 3, 2002, and is headquartered in Greenwich, CT.

QXO Inc.

QXO is trending as traders express frustration over sustained downward price action and 52-week lows, which many attribute to macroeconomic headwinds like high interest rates and broader industry weakness. While some investors remain optimistic about the long-term potential of CEO Brad Jacobs' M&A strategy, significant debate persists regarding the impact of share dilution and the lack of immediate catalysts to spark a recovery.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is experiencing heightened volatility and skepticism as the Senate holds a procedural vote on the Digital Asset Market Clarity Act, with traders divided on whether the bill will advance or if its rejection is already priced in. Community discussion is dominated by debate over the bill's legislative chances, concerns about broader macroeconomic pressures like Fed interest rate decisions, and conflicting opinions on whether regulation serves as a catalyst for growth or a sell-the-news event.

Western Digital Corp. engages in the development, manufacture, marketing, and sale of data storage devices and solutions. It operates through the Hard Disk Drives (HDD) segment. The company was founded by Alvin B. Phillips in 1970 and is headquartered in San Jose, CA.

Western Digital Corp.

Western Digital shares are facing volatility as traders debate the sustainability of the memory and storage supercycle, with many dismissing recent price drops as market manipulation or a temporary correction. While some investors remain bullish, citing strong AI infrastructure demand and fundamental growth, others are concerned about overextended valuations and potential demand cooling.

statis crypto Watchlist

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Decoy Therapeutics Expands Intellectual Property Portfolio Covering Designable Multi-Antivirals and the IMPACT Platform

Decoy Therapeutics Expands Intellectual Property Portfolio Covering Designable Multi-Antivirals and the IMPACT Platform Decoy Therapeutics Expands Intellectual Property Portfolio Covering Designable Multi-Antivirals and the IMPACT Platform PR Newswire CAMBRIDGE, Mass., Aug. 3, 2026 Portfolio now...

Decoy Therapeutics Announces Breakthrough In Vitro Activity Against Ebola Zaire, Expanding D-MAV Platform into High Consequence Global Health Threats

Decoy Therapeutics Announces Breakthrough In Vitro Activity Against Ebola Zaire, Expanding D-MAV Platform into High Consequence Global Health Threats Decoy Therapeutics Announces Breakthrough In Vitro Activity Against Ebola Zaire, Expanding D-MAV Platform into High Consequence Global Health Threats...

Decoy Therapeutics Stockholders Elect Patricia Gauthier to Board of Directors

Decoy Therapeutics Stockholders Elect Patricia Gauthier to Board of Directors Decoy Therapeutics Stockholders Elect Patricia Gauthier to Board of Directors PR Newswire CAMBRIDGE, Mass., July 15, 2026 CAMBRIDGE, Mass., July 15, 2026 /PRNewswire/ -- Decoy Therapeutics Inc. (Nasdaq: DCOY), a...

12 Health Care Stocks Moving In Monday's Intraday Session

Gainers

Universe Pharmaceuticals (NASDAQ:UPC) stock moved upwards by 284.8% to $11.39 during Monday's regular session. The company's market cap stands at $1.9 million.
Decoy Therapeutics (NASDAQ:DCOY) sharesread more...

DCOY Stock Nearly Doubled In Value Today – What’s Driving This Mega Rally?

Equity

Decoy Therapeutics has secured funding to begin clinical trials for its programs targeting respiratory illnesses.


Decoy Therapeutics Secures Milestone-Based Financing to Advance Antiviral Pipeline

Decoy Therapeutics (NASDAQ:DCOY) announced a private investment in public equity (PIPE) financing that could provide the biotechnology company with up to approximately $21 million in gross proceeds through a combination of upfront funding and milestone-based warrant exercises. The initial closing is expected to generate approximately $3.5 million, with additional capital becoming available if specified clinical, regulatory, and shareholder approval milestones are achieved. The company said it intends to use the proceeds to advance its lead antiviral candidate into clinical trials.

4 Sizzling Biotech and Healthcare Companies Reporting Strategic Milestones

As the second half of 2026 begins, a series of regulatory approvals, strategic acquisitions, clinical development milestones, and financing initiatives are highlighting continued activity across the biotechnology and healthcare sectors, as companies work to expand pipelines, strengthen balance sheets, and advance toward commercialization. $UPC, $NTHI, $DCOY, $VRDN

12 Health Care Stocks Moving In Monday's Pre-Market Session

Gainers

Universe Pharmaceuticals (NASDAQ:UPC) stock moved upwards by 159.6% to $7.68 during Monday's pre-market session. The company's market cap stands at $1.9 million.
Decoy Therapeutics (NASDAQ:DCOY) stockread more...

Decoy Therapeutics, Inc. Announces Up to $21 Million Private Placement Financing

Decoy Therapeutics, Inc. Announces Up to $21 Million Private Placement Financing Decoy Therapeutics, Inc. Announces Up to $21 Million Private Placement Financing PR Newswire HOUSTON, June 26, 2026 HOUSTON, June 26, 2026 /PRNewswire/ -- Decoy Therapeutics, Inc. (NASDAQ: DCOY) (the "Company" or...

Decoy Therapeutics' CEO to Participate in hVIVO Capital Markets Day in London

Decoy Therapeutics' CEO to Participate in hVIVO Capital Markets Day in London Decoy Therapeutics' CEO to Participate in hVIVO Capital Markets Day in London PR Newswire CAMBRIDGE, Mass., June 8, 2026 Rick Pierce to join speakers from Boehringer Ingelheim, RA Capital and ILiAD Biotechnologies for...

Decoy Therapeutics, Inc. operates as a preclinical-stage biotechnology company. It engages in leveraging machine learning and AI tools alongside high-speed synthesis techniques to rapidly design, engineer and manufacture peptide conjugate drug candidates that target serious unmet medical needs. The company was founded by Frederick E. Pierce, Barbara Hibner, Peter Marschel, Michael Lipp, and Jodi Cooper in 2020 and is headquartered in Houston, TX.

Decoy Therapeutics Inc.

Neutral Sentiment

50bps hike

25bps hike

No change

25bps cut

The Federal Reserve's September FOMC meeting concludes Wednesday, September 16, with a rate decision due at 2:00 PM ET, following Tuesday's CPI report that showed inflation still running above the Fed's 2% target. What do you think the Fed decides at this week's FOMC meeting? Vote and explain your reasoning in the comments.

The Fed&#39;s rate decision comes Wednesday at 2PM ET. What do you think happens?

Stocktwits

The Fed's rate decision comes Wednesday at 2PM ET. What do you think happens?

Current Price	$2.69
Prev Close	$2.71
Open	$2.72
Dividend Yield	0.00%
50-Day Moving Average	$4.12
Beta	0.20
Avg. Volume	27,329.54
PE Ratio	-0.06

52-Week High	$70.80
52-Week Low	$2.60
Market Capitalization	$1.78M
EPS (Annual)	-$129.10
Price to Book	0.33
Revenue Per Employee	$0.00

Feed

News

Sentiment

Fundamentals

Info

DCOY Fundamentals